A93 LATENT TUBERCULOSIS SCREENING PRIOR TO BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS: IS THE CHEST X-RAY ALWAYS NEEDED?

摘要

BackgroundInflammatory bowel disease (IBD) patients undergoing treatment with biological therapy are at increased risk of developing opportunistic infections such as tuberculosis (TB). Screening for latent tuberculosis is mandatory before initiating biological therapy such as Anti-TNF alpha. Most IBD guidelines include QuantiFERON Tb Gold (QTF), Tuberculin Skin Test (TST) and/or chest X-ray as screening methods.